Transferability of real-world data across borders for regulatory and health technology assessment decision-making
Recently, there has been increased consideration of real-world data (RWD) and real-world evidence (RWE) in regulatory and health technology assessment (HTA) decision-making. Due to challenges in identifying high-quality and relevant RWD sources, researchers and regulatory/HTA bodies may turn to RWD...
Main Authors: | Ashley Jaksa, Patrick J. Arena, Kelvin K. W. Chan, Rami H. Ben-Joseph, Páll Jónsson, Ulka B. Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1073678/full |
Similar Items
-
Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
by: Patrick Maison, et al.
Published: (2022-07-01) -
Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop
by: Ravinder Claire, et al.
Published: (2024-01-01) -
Real-world evidence for regulatory decision-making: updated guidance from around the world
by: Leah Burns, et al.
Published: (2023-10-01) -
Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications
by: Zou KH, et al.
Published: (2020-07-01) -
How Do People Make Relevance Judgment of Scientific Data?
by: Jianping Liu, et al.
Published: (2020-03-01)